Physician

John A Friedline, MD

According to 2025 Medicare claims, John Friedline, MD (NPI: 1447311261) practices family practice in the El Centro, CA market, with the plurality of this provider's patient population coming from Imperial, CA. This provider's primary affiliated billing organization is LA SUAREZ A PROFESSIONAL CORPORATION (NPI: 1841074267; TIN: 92-3494903) and primary practice location at 92243-4165. Friedline is affiliated with the Aledade 60 CA MSSP Enhanced (ACO ID: A4775), participating under the MSSP model.

Friedline's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 294 traditional Medicare patients, billed 4,482 HCPCS/CPT codes, and received $177,875 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 12,246 prescription claims across 789 beneficiaries totaling $1,609,663 in drug costs, led by Mounjaro (Tirzepatide). DME data shows 170 claims. Open Payments data shows 22 records totaling $439. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $77,203 to $177,875. Similarly, Part D prescription costs have moved sharply higher in recent years, from $485,140 to $1,609,663. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $20,486 and ending at $20,929.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	383	1,557	$77,203
2016	418	1,547	$75,455
2017	480	1,357	$63,006
2018	420	3,027	$136,106
2019	423	3,941	$171,649
2020	249	2,407	$94,356
2021	282	3,463	$154,239
2022	310	4,368	$192,615
2023	279	3,919	$180,118
2024	294	4,482	$177,875

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	322	7,781	$485,140
2016	394	8,934	$505,142
2017	514	7,642	$407,885
2018	613	5,369	$320,545
2019	633	7,348	$553,922
2020	530	7,057	$622,941
2021	524	6,694	$603,336
2022	585	9,452	$1,021,067
2023	694	11,784	$1,739,058
2024	789	12,246	$1,609,663

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	81	465	$88,934
2016	77	425	$86,451
2017	63	422	$46,161
2018	53	290	$22,019
2019	34	170	$3,412
2020	33	175	$4,753
2021	38	151	$9,035
2022	46	287	$10,923
2023	50	242	$13,374
2024	42	170	$10,781

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	129	129	$132
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	204	491	$102
99497	Advance care planning, first 30 minutes	195	295	$70
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	240	727	$68
G0444	Annual depression screening, 5 to 15 minutes	125	125	$20

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Mounjaro	Tirzepatide	152	4,686	$157,215
Ozempic	Semaglutide	99	4,180	$125,655
Rybelsus	Semaglutide	80	4,260	$124,757
Jardiance	Empagliflozin	71	3,690	$68,086
Trulicity	Dulaglutide	45	2,090	$66,635

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	18	$6,691
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	34	$2,176
E1392	Portable oxygen concentrator, rental	Y	N/R	32	$1,036
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	25	58	$837
A4259	Lancets, per box of 100	N	17	28	$41

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	22	$439	Alnylam Pharmaceuticals Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for John A. Friedline, MD?

Tedicare shows public-source Medicare data for John A. Friedline, MD (NPI 1447311261), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John A. Friedline, MD have ACO affiliation data?

John A. Friedline, MD is shown with ACO affiliation data for Aledade 60 CA MSSP Enhanced (MSSP, ACO ID A4775).

What billing organization is linked to John A. Friedline, MD?

John A. Friedline, MD is linked to LA SUAREZ A PROFESSIONAL CORPORATION (billing NPI 1841074267) in the available physician profile data.

Does John A. Friedline, MD have Open Payments data?

John A. Friedline, MD has 22 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.